GSK set aside $3.4bn in last quarter of 2010 to cover legal costsBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d488 (Published 24 January 2011) Cite this as: BMJ 2011;342:d488
- Janice Hopkins Tanne
- 1New York
GlaxoSmithKline has set aside $3.4bn (£2.1bn; €2.5bn) to cover legal costs in the fourth quarter of last year. That amount wipes out the company’s profit for the fourth quarter, the news agency Reuters has reported. However, a GSK spokeswoman said that she could not give sales projections as they would be reported on 3 February.
In July the company set aside $2.36bn to cover costs related to product liability cases settled or received at that time and other problems, bringing the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial